EMD-16676

Single-particle
2.7 Å
EMD-16676 Deposition: 09/02/2023
Map released: 21/02/2024
Last modified: 06/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-16676

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-8cii summary report (pdf.gz) Map-8cii FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

Delta-RBD complex with BA.2-07 fab, SARS1-34 fab and C1 nanobody

EMD-16676

Single-particle
2.7 Å
EMD-16676 Deposition: 09/02/2023
Map released: 21/02/2024
Last modified: 06/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2, Lama glama
Sample: Delta-RBD complex with BA.2-07 fab, SARS1-34 fab and C1 nanobody
Fitted models: 8cii

Deposition Authors: Duyvesteyn HME , Ren J , Stuart DI , Fry EE

Potent cross-reactive mAbs from BA.4/5 breakthrough infection